BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
147 hedge funds and large institutions have $445M invested in BioDelivery Sciences International, Inc. in 2015 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 20 closing their positions.
163% more call options, than puts
Call options by funds: $26.5M | Put options by funds: $10.1M
65% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 20
61% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 36
9% more funds holding
Funds holding: 135 → 147 (+12)
9% less capital invested
Capital invested by funds: $489M → $445M (-$44.4M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$21.6M |
| 2 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$15.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$15.5M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$6.83M |
| 5 |
PC
PointState Capital
New York
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.8M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$15.2M |
| 3 |
PA
Perceptive Advisors
New York
|
-$7.28M |
| 4 |
DM
Deerfield Management
New York
|
-$5.58M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$5.34M |
BDSI Hedge Fund Activity: Q1 2015 in Review
147 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2015, worth a combined $445M — down 9.1% from $489M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new BDSI positions and 20 closed out — a net gain of 13 holders — while 58 added to existing stakes and 36 trimmed.
The largest buyer was Millennium Management, adding an estimated $21.6M. The largest seller was Fidelity Investments, cutting an estimated $19.8M.
- 147 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2015, up from 135 in Q4 2014.
- Funds reported $445M of BioDelivery Sciences International, Inc. stock for Q1 2015, down 9.1% quarter-over-quarter.
- 33 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2015 and 20 closed out, a net change of +13 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2015 was Millennium Management, an estimated $21.6M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2015 was Fidelity Investments, an estimated $19.8M sold.
Based on aggregated 13F filings for Q1 2015.